1. ICD-10-CM Codes
›
2. D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
›
3. D60-D64 Aplastic and other anemias and other bone marrow failure syndromes
›
4. D60- Acquired pure red cell aplasia [erythroblastopenia]
›
5. 2022 ICD-10-CM Diagnosis Code D60.9

2022 ICD-10-CM Diagnosis Code D60.9

Acquired pure red cell aplasia, unspecified

2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code

• D60.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
• The 2022 edition of ICD-10-CM D60.9 became effective on October 1, 2021.
• This is the American ICD-10-CM version of D60.9 - other international versions of ICD-10 D60.9 may differ.

• Acquired adult red cell aplasia due to thymoma
• Acquired adult red cell aplasia with thymoma
• Acquired pure red cell aplasia
• Pure red cell aplasia, acquired

• A disease characterized by normocytic, normochromic anemia, low hematocrit, reticulocytopenia and selective erythroid hypoplasia. It can occur as a chronic or acute form; the former is predominantly seen in adults and the latter in children. Pathogenesis involves immune dysfunction with antibodies directed against erythroid precursor cells or erythropoietin, or due to t-cell mediated suppression of erythropoiesis.
• A rare disorder in which the bone marrow makes almost no red blood cells. It may be caused by infection or by certain drugs. Patients with this disorder may also have a thymoma (a tumor of the thymus) or an autoimmune condition such as lupus erythematosus or rheumatoid arthritis.

• 808 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with mcc
• 809 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with cc
• 810 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders without cc/mcc

Convert D60.9 to ICD-9-CM

• 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
• 2017 (effective 10/1/2016): No change
• 2018 (effective 10/1/2017): No change
• 2019 (effective 10/1/2018): No change
• 2020 (effective 10/1/2019): No change
• 2021 (effective 10/1/2020): No change
• 2022 (effective 10/1/2021): No change

• Type 1 Excludes: D61.01
  ICD-10-CM Diagnosis Code D61.01

  Constitutional (pure) red blood cell aplasia

  2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code

  Applicable To

  • Blackfan-Diamond syndrome
  • Congenital (pure) red cell aplasia
  • Familial hypoplastic anemia
  • Primary (pure) red cell aplasia
  • Red cell (pure) aplasia of infants

  Type 1 Excludes

  • acquired red cell aplasia (D60.9)

• Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) D64.9
  ICD-10-CM Diagnosis Code D64.9

  Anemia, unspecified

  2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code
  • aplastic D61.9
    ICD-10-CM Diagnosis Code D61.9

    Aplastic anemia, unspecified

    2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code

    Applicable To

    • Hypoplastic anemia NOS
    • Medullary hypoplasia
    • red cell (pure) D60.9
  • pure red cell D60.9
• Aplasia - see also Agenesis
  • red cell (with thymoma) D60.9
    • acquired D60.9
      • due to drugs D60.9
    • pure D61.01
      ICD-10-CM Diagnosis Code D61.01

      Constitutional (pure) red blood cell aplasia

      2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code

      Applicable To

      • Blackfan-Diamond syndrome
      • Congenital (pure) red cell aplasia
      • Familial hypoplastic anemia
      • Primary (pure) red cell aplasia
      • Red cell (pure) aplasia of infants

      Type 1 Excludes

      • acquired red cell aplasia (D60.9)
      • due to drugs D60.9
    • adult D60.9
    • due to drugs D60.9
• Erythroblastopenia D60.9 - see also Aplasia, red cell

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.